Revenue YoY
—
Operating Income YoY
+41.12%
Net Income YoY
+43.20%
Net Margin Δ
—
Net income bridge for Climb Bio (CLYM) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $40.2M+43.20%
Profit bridge breakdown for Climb Bio (CLYM) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | -$93M | — |
| Revenue | $0.00 | +0.0% |
| Cost of Revenue | -$106K | -0.3% |
| Operating Expenses | $42.1M | +104.7% |
| Other Income / Expense | -$1.77M | -4.4% |
| Income Tax | $0.00 | -0.0% |
| Net Loss | -$52.8M | — |
- Prior Net Income-$93M
- Revenue$0.00
- Cost of Revenue-$106K
- Operating Expenses$42.1M
- Other Income / Expense-$1.77M
- Income Tax$0.00
- Net Loss-$52.8M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.